Business / Finance

RSS

Teleflex net revenues increase 12.4% to $413.8 million in third quarter 2013

Teleflex Incorporated today announced financial results for the third quarter ended September 29, 2013.

30 Oct 2013

MiMedx Group reports record revenue in third quarter 2013

MiMedx Group, Inc., an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today its results for the quarter ended September 30, 2013.

30 Oct 2013

Immune Design closes Series C financing totalling up to $49M

Immune Design, a biotechnology company focused on the development of novel immune-based therapies for cancer and other chronic conditions, today announced it has closed a Series C financing totalling up to $49 million.

30 Oct 2013

Cvrx closes additional $12 million under its Series F financing

CVRx, Inc., a privately held medical device company, has closed on an additional $12 million under its Series F financing. This brings the total raised in the Series F financing to $42 million.

30 Oct 2013

USCB acquires ReMed Recovery Care Centers

US Community Behavioral, LLC ("USCB"), a leading multi-state provider of community-based residential and behavioral services, announced it has acquired ReMed Recovery Care Centers, LLC, a highly regarded provider of brain injury rehabilitation services based in Pennsylvania.

30 Oct 2013

Wiley expands partnership with EMBO

John Wiley & Sons, Inc., today announced that it will provide editorial production, global marketing and distribution services for The EMBO Journal, EMBO reports and Molecular Systems Biology. This expanded partnership with EMBO adds three leading scientific journals alongside EMBO Molecular Medicine, which Wiley has published since 2009.

30 Oct 2013

Aetna’s operating earnings increase 7% to $561.8M in third-quarter 2013

Aetna announced third-quarter 2013 operating earnings of $561.8 million, an increase of 7 percent over the third quarter of 2012. Third-quarter operating earnings per share were $1.50 in 2013 and $1.55 in 2012.

29 Oct 2013

Cytrx announces Q3 2013 financial results, provides clinical update

CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today reported financial results for the three and nine-month periods ended September 30, 2013, and provided a clinical update.

29 Oct 2013

BioGaia gets exclusive rights to sell oral health products

BioGaia has signed four different distribution agreements for the exclusive rights to sell its oral health products.

29 Oct 2013

PulseOn closes €1M seed investment round to launch innovation in optical heart rate monitoring

Finnish mobile wellness technology company PulseOn has closed a €1m seed investment round to finalize and launch its ground-breaking innovation in optical heart rate monitoring.

29 Oct 2013

Biogen Idec Q3 total revenues increase 32% to $1.8 billion

Biogen Idec Inc. today reported third quarter 2013 total revenues of $1.8 billion, an increase of 32% over the third quarter of 2012. Non-GAAP diluted EPS for the third quarter of 2013 were $2.35, an increase of 23% over the third quarter of 2012.

28 Oct 2013

Middle Peak Medical raises additional $3M in Series A financing

Middle Peak Medical, a development-stage medical device company that will commercialize a novel technology for treating mitral valve disease, has raised an additional $3M in a second closing of its over-subscribed Series A financing, which now totals approximately $11M.

28 Oct 2013

Haemonetics net revenue increases 8% to $235.8 million in Q2 fiscal 2014

Haemonetics Corporation today reported second quarter fiscal 2014 net revenue of $235.8 million, up 8%, GAAP net income of $16.5 million and earnings per share of $0.32. Adjusted net income, exclusive of transformation, integration and deal amortization expenses detailed below, was $34.4 million, up 24%, and adjusted earnings per share were $0.66, up 24%. Excluding currency impact, net revenue was up 11% in the quarter.

28 Oct 2013

DSM, Sanquin Make Factor IX-Recovering Mab Manufacturing Deal

...

24 Oct 2013

Mckesson's $8.3B Celesio Deal Builds Drug Warehousing Powerhouse

...

24 Oct 2013

Adcare Health Systems prices underwritten public offering of Series A Preferred Stock

AdCare Health Systems, Inc. the "Company") announced today that it has priced a "best efforts" underwritten public offering of its 10.875% Series A Cumulative Redeemable Preferred Stock (the "Series A Preferred Stock") at a public offering price of $25.00 per share.

24 Oct 2013

Life Time Fitness' revenues increase 7.2% to $316M in third quarter 2013

Life Time Fitness, Inc., The Healthy Way of Life Company, today reported its financial results for the third quarter ended September 30, 2013.

24 Oct 2013

McKesson’s revenues increase 11% to $33B in second quarter 2014

McKesson Corporation (NYSE:MCK) today reported that revenues for the second quarter ended September 30, 2013 were $33 billion, up 11% compared to $29.8 billion a year ago. On the basis of U.S. generally accepted accounting principles ("GAAP"), second-quarter earnings per diluted share was $1.74 compared to $1.67 a year ago.

24 Oct 2013

The Wellness Network announces acquisition of LOGICARE

The Wellness Network, parent company of The Patient Channel, The Newborn Channel, and HealthStyle Press, today announced that it has acquired LOGICARE Corporation, a leading hospital patient education software company.

24 Oct 2013

Zimmer Holdings net sales increase 4.8% to $1.07 billion in Q3 2013

Zimmer Holdings, Inc. today reported financial results for the quarter ended September 30, 2013. The Company reported third quarter net sales of $1.07 billion, an increase of 4.8% reported and 6.7% constant currency over the third quarter of 2012

24 Oct 2013